Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 108 | 97 | 99 | 98 | 106 | 102 | 101 | 107 | 119 | 120 | 126 | 126 |
| Expenses | 83 | 76 | 76 | 80 | 82 | 81 | 81 | 90 | 96 | 99 | 103 | 102 |
| Operating Profit | 25 | 21 | 23 | 18 | 23 | 21 | 21 | 17 | 23 | 21 | 23 | 24 |
| OPM % | 23% | 22% | 23% | 18% | 22% | 21% | 20% | 16% | 19% | 17% | 18% | 19% |
| Other Income | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Depreciation | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 | 7 | 7 | 7 | 7 |
| Profit before tax | 19 | 16 | 18 | 15 | 21 | 18 | 16 | 11 | 15 | 13 | 16 | 17 |
| Tax % | 31% | 28% | 30% | 32% | 28% | 30% | 21% | 31% | 30% | 27% | 8% | 26% |
| Net Profit | 14 | 11 | 13 | 10 | 15 | 12 | 13 | 8 | 11 | 9 | 15 | 13 |
| EPS in Rs | 1.69 | 1.44 | 1.56 | 1.21 | 1.81 | 1.49 | 1.57 | 0.94 | 1.29 | 1.14 | 1.78 | 1.55 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 243 | 337 | 361 | 400 | 407 | 473 | 492 |
| Expenses | 176 | 194 | 263 | 287 | 312 | 324 | 387 | 401 |
| Operating Profit | 36 | 49 | 74 | 74 | 88 | 83 | 85 | 91 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% | 19% |
| Other Income | 4 | 6 | 5 | 6 | 5 | 8 | 5 | 6 |
| Interest | 14 | 14 | 11 | 9 | 7 | 3 | 8 | 9 |
| Depreciation | 11 | 12 | 14 | 15 | 18 | 19 | 27 | 28 |
| Profit before tax | 15 | 29 | 54 | 56 | 68 | 69 | 55 | 61 |
| Tax % | 26% | 27% | 23% | 30% | 30% | 28% | 23% | |
| Net Profit | 11 | 21 | 42 | 39 | 48 | 50 | 42 | 47 |
| EPS in Rs | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 5.15 | 5.76 |
| Dividend Payout % | 0% | 47% | 0% | 102% | 60% | 41% | 49% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 14% | 9% | 18% | ||
| Compounded Profit Growth | % | 16% | 4% | -1% | ||
| Stock Price CAGR | % | % | % | 5% | ||
| Return on Equity | % | 22% | 21% | 17% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 187 |
| Borrowings | 157 | 166 | 102 | 82 | 31 | 35 | 91 |
| Other Liabilities | 25 | 18 | 63 | 79 | 96 | 101 | 104 |
| Total Liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
| Fixed Assets | 226 | 220 | 220 | 228 | 224 | 228 | 342 |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 1 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 43 |
| Other Assets | 80 | 97 | 92 | 83 | 85 | 78 | 79 |
| Total Assets | 308 | 317 | 323 | 327 | 346 | 384 | 465 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 41 | 43 | 66 | 66 | 69 | 67 | 81 |
| Cash from Investing Activity | -54 | -16 | -5 | 5 | -25 | -33 | -47 |
| Cash from Financing Activity | 12 | -22 | -57 | -73 | -48 | -35 | -31 |
| Net Cash Flow | -1 | 4 | 3 | -2 | -5 | -0 | 2 |
| Free Cash Flow | -5 | 38 | 59 | 58 | 50 | 18 | 40 |
| CFO/OP | 116% | 88% | 107% | 103% | 95% | 101% | 110% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 26 | 15 | 21 | 22 | 18 | 16 |
| Inventory Days | 60 | 41 | 30 | 43 | 36 | 41 | 43 |
| Days Payable | 314 | 165 | 121 | 161 | 165 | 161 | 170 |
| Cash Conversion Cycle | -224 | -98 | -76 | -97 | -106 | -102 | -112 |
| Working Capital Days | -4 | 32 | 3 | -18 | -16 | -28 | -29 |
| ROCE % | 14% | 23% | 25% | 30% | 27% | 20% |
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% | 65.57% |
| FIIs | 6.68% | 5.38% | 4.70% | 4.71% | 4.49% | 4.96% | 3.20% | 2.73% | 2.81% | 3.03% |
| DIIs | 11.61% | 11.88% | 10.80% | 11.30% | 11.35% | 9.33% | 6.45% | 6.20% | 6.84% | 6.94% |
| Public | 16.14% | 17.16% | 18.92% | 18.41% | 18.59% | 20.14% | 24.77% | 25.48% | 24.79% | 24.46% |
| No. of Shareholders | 76,664 | 71,293 | 74,737 | 70,147 | 68,365 | 67,060 | 67,617 | 66,626 | 64,075 | 62,454 |
Fundamentals
Market Cap₹ 1,262 Cr.
Current Price₹ 154
Stock P/E26.7
Book Value₹ 32.8
ROCE19.9 %
ROE16.7 %
Dividend Yield1.63 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)18%
Compounded Profit Growth (TTM)-1%
Standalone figures.
Valuation
Market capRs 1,210 Cr
Enterprise valueRs 1,284 Cr
P/E (TTM)25.60x
Price to book7.32x
Price to sales2.46x
EV / EBITDA13.18x
EV / EBIT18.44x
EV / sales2.61x
Price to cash flow18.24x
Earnings yield3.91%
Dividend yield3.30%
Profitability
Operating margin (excl. other income)20.59%
Operating margin (incl. other income)22.17%
EBITDA margin19.81%
Pre-tax margin12.38%
Net profit margin9.61%
Net margin, latest quarter10.09%
ROE24.11%
ROCE25.67%
ROA12.00%
ROE, 3-year average22.94%
ROCE, 3-year average21.20%
ROA, 3-year average10.58%
ROIC (approx.)20.31%
Tax rate30.30%
Other income / net worth3.44%
Growth
Sales growth (latest year)7.00%
Profit growth (latest year)-6.36%
Sales CAGR, 3 years19.45%
Profit CAGR, 3 years52.68%
Sales growth QoQ-0.13%
Profit growth QoQ-12.63%
Sales growth YoY (latest quarter)17.82%
Profit growth YoY (latest quarter)65.76%
Per share
EPS (TTM)Rs 5.92
EPS (latest year)Rs 4.88
EPS (latest quarter)Rs 1.59
EPS, 3-year averageRs 7.28
Book value per shareRs 20.69
Sales per shareRs 61.53
Cash flow per shareRs 8.30
Free cash flow per shareRs 5.01
Dividend per share (latest year)Rs 5.00
Dividend per share, 3-year averageRs 5.25
Dividends
Dividend payout102.41%
Dividend payout, 3-year average74.60%
Efficiency
Asset turnover1.10x
Fixed asset turnover1.58x
Inventory turnover21.73x
Inventory days17 days
Debtor days21 days
Debtors turnover17.46x
Creditor days170 days
Cash conversion cycle-112 days
Working capital days-29 days
Leverage
Total debtRs 82 Cr
Cash and bankRs 9 Cr
Net debtRs 74 Cr
Debt to equity0.50x
Net debt / EBITDA0.75x
Interest coverage7.95x
Current ratio (filing 2026-03-31)1.12x
Quick ratio (filing 2026-03-31)0.99x
Trade payables (filing 2026-03-31)Rs 42 Cr
Owners' fund to total sources50.61%
Debt to assets25.20%
Cash flow
Cash from Operating Activity (latest year)Rs 66 Cr
Cash from Investing Activity (latest year)Rs 5 Cr
Cash from Financing Activity (latest year)Rs -73 Cr
Net Cash Flow (latest year)Rs -2 Cr
Free cash flow (latest year)Rs 40 Cr
FCFE (approx.: FCF + change in debt)Rs 21 Cr
Cash from ops / profit, 5 years1.58x
Sales to cash flow5.44x
Statement figures
Net sales (TTM)Rs 492 Cr
Net sales (latest year)Rs 361 Cr
Sales (latest quarter)Rs 126 Cr
Operating profit excl. other income (latest year)Rs 74 Cr
Operating profit (latest quarter)Rs 24 Cr
Other income (TTM)Rs 6 Cr
EBITDA (TTM)Rs 97 Cr
PBDT (TTM)Rs 89 Cr
Profit before tax (TTM)Rs 61 Cr
Tax (latest year)Rs 17 Cr
Net profit (TTM)Rs 47 Cr
Net profit (latest year)Rs 39 Cr
Net profit (latest quarter)Rs 13 Cr
Depreciation (TTM)Rs 28 Cr
Depreciation (latest quarter)Rs 7 Cr
Interest (TTM)Rs 9 Cr
Cost of goods sold (latest year)Rs 194 Cr
Total expenditure (latest year)Rs 287 Cr
Total income (latest year)Rs 367 Cr
Share capitalRs 80 Cr
ReservesRs 85 Cr
Shareholders' fundsRs 165 Cr
Total assetsRs 327 Cr
Net blockRs 228 Cr
Capital work in progressRs 3 Cr
InvestmentsRs 13 Cr
ReceivablesRs 21 Cr
InventoryRs 9 Cr
Other liabilitiesRs 79 Cr
Shares outstanding (crore)7.99
Ownership
Promoter holding65.57% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 25.6 is at the 36th percentile of its own 2.8-year range
(median 26.9, low 21.0, high 146.3).
P/B 7.32 is at the 27th percentile (median 8.24).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | GPTHEALTH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -6.3% | -2.8% | -3.6 pts |
| 1 month | -0.1% | -6.8% | +6.7 pts |
| 3 months | -4.6% | -7.6% | +3.0 pts |
| 6 months | +31.4% | +0.4% | +31.0 pts |
| 1 year | +3.0% | -9.9% | +13.0 pts |
| 2 years | -17.6% | -13.6% | -4.0 pts |
3 mutual fund schemes hold about ₹58 Cr.
Over three months 1 bought more and 1 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Bandhan Small Cap Fund | 0.15% | 50 | -10% |
| Bandhan Infrastructure Fund | 0.55% | 8 | +10% |
| Bandhan BSE Healthcare Index Fund | 0.03% | 0 | +5% |
Red flags
F-score 6 of 8| explain | Share dilution Share count up 0% in a year, 346% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹126 Cr +17.8% vs Jun 2025.
Net profit ₹13 Cr +62.5%.
Against our estimate for Jun 2026: sales -2.8%, profit +19.7% beat. Our estimate for Sep 2026: sales Rs 144 Cr, profit Rs 14 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Narayana Hrudayalaya Ltd | 36,579 | 42.4 | 15.5 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-07-30 | Dividend - Rs1.50 Per Share | |
| 2025-11-14 | Interim Dividend - Re 1 Per Share | |
| 2025-07-29 | Dividend - Rs 1.50 Per Share | |
| 2024-11-28 | Interim Dividend - Re 1 Per Share | |
| 2024-07-18 | Annual General Meeting/Dividend - Rs 1.50 Per Share | |
| 2024-04-02 | Interim Dividend - Re 1 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of GPT Healthcare Ltd?
GPT Healthcare Ltd (GPTHEALTH) has a market capitalisation of Rs 1,262 Cr. at the 2026-10-01 close.
What is the P/E ratio of GPT Healthcare Ltd?
GPT Healthcare Ltd trades at a P/E of 26.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were GPT Healthcare Ltd's latest quarterly results?
In the Jun 2026 quarter, GPT Healthcare Ltd sales was Rs 126 Cr (+17.8% vs Jun 2025) and net profit was Rs 13 Cr.
What is the 52-week high and low of GPT Healthcare Ltd?
The 52-week high is Rs 175.00 and the 52-week low is Rs 115.00.